A 3D model of the {delta} opioid receptor and ligand-receptor complexes

A model for the 3D structure of the transmembrane domain ofthe opioid receptor was predicted from the sequence divergenceanalysis of 42 sequences of G-protein coupled peptide hormonereceptors belonging to the opioid, somatostatin and angiotensinreceptor families. No template was used in the prediction steps,which include multiple sequence alignment, calculation of avariability profile of the aligned sequences, use of the variabilityprofile to identify the boundaries of transmembrane regions,prediction of their secondary structure, optimization of thepacking shape in a helix bundle, prediction of side chain conformationsand structural refinement The general shape of the model issimilar to that of the low resolution rhodopsin structure inthat the TM3 and TM7 helices are most buried in the bundle andthe TM1 and TM4 helices are most exposed to the lipid phase.An initial assessment of this model was made by determiningto what extent a binding site identified using four structurallydisparate high affinity opioid ligands was consistent withknown mutational studies. With the assumption that the pro-tonatedamine nitrogen, a feature common to all opioid ligands, interactswith the highly conserved Aspl27 in TM3, a pocket was foundthat satisfied the criteria of complementarity to the requirementsfor receptor recognition for these four diverse ligands, two selective antagonists (the fused ring naltrindole and the peptideTyr-Tic-Phe-Phe-NH₂) and the two agonists lofentanil and BW373U86deduced from previous studies of the ligands alone. These ligandscould be accommodated in a similar region of the receptor. Thereceptor binding site identified in the optimized complexescontained many residues in positions known to affect ligandbinding in G-protein coupled receptors. These results also allowedidentification of key residues as candidates for point mutationsfor further assessment and refinement of this model as wellas preliminary indications of the requirements for recognitionof this receptor.